Early central catheter infections may contribute to hepatic fibrosis in children receiving long-term parenteral nutrition

Journal of Pediatric Gastroenterology and Nutrition

Volumn 44, Issue 4, 2007, Pages 459-463

  Hermans, Dominique ^a   Talbotec, Cécile ^b   Lacaille, Florence ^b   Goulet, Olivier ^b   Ricour, Claude ^b   Colomb, Virginie ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Children; Cholestasis; Infection; Liver fibrosis; Parenteral nutrition; Sepsis

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AZATHIOPRINE; BETA LACTAM ANTIBIOTIC; COLESTYRAMINE; CORTICOSTEROID; CYCLOSPORIN; FLUCONAZOLE; FOSFOMYCIN; GANCICLOVIR; GLYCOPEPTIDE; METRONIDAZOLE; NEOMYCIN; RANITIDINE; RIFAMYCIN; SOMATOSTATIN; SULFANILAMIDE; URINARY TRACT ANTIINFECTIVE AGENT; URSODEOXYCHOLIC ACID;

ARTICLE; BACTERIAL INFECTION; BIRTH WEIGHT; CATHETER INFECTION; CHILD; CHOLESTASIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; INFANT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LONG TERM CARE; MALE; PARENTERAL NUTRITION; PRIORITY JOURNAL; PSEUDOOBSTRUCTION; RETROSPECTIVE STUDY; SEPSIS; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; URINARY TRACT INFECTION; VESICOURETERAL REFLUX;

BACTERIAL INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; FEMALE; HUMANS; INFANT; INTESTINAL DISEASES; LIVER CIRRHOSIS; MALE; PARENTERAL NUTRITION; TIME FACTORS;

BACTERIA (MICROORGANISMS);

EID: 34147110953     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318031a5c7     Document Type: Article

References (28)

1. Kelly DA. Intestinal failure-associated liver disease: what do we know today? Gastroenterology 2006;130 (Suppl 1):S70-7.
2. Colomb V, Goulet O, Rambaud C, et al. Long term-parenteral nutrition (PN) in children: liver and gallbladder disease. Transplant Proc 1992;24:1054-5.
3. Angelico M, Della Guardia P. Review article: hepatobiliary complications associated with total parenteral nutrition. Aliment Pharmacol Ther 2000;14:54-7.
4. Shulman RJ. New developments in total parenteral nutrition for children. Curr Gastroenterol Rep 2000;2:253-8.
5. Owings E, Georgeson K. Management of cholestasis in infants with very low birth weight. Semin Pediatr Surg 2000;9 (2):96-102.
6. Forchielli ML, Walker WA. Nutritional factors contributing to the development of cholestasis during total parenteral nutrition. Adv Pediatr 2003;50:245-67.
7. Beath SV, Davies P, Papadopoulo A, et al. Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg 1996;31:604-6.
8. Sondheimer JM, Asturias E, Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 1998;27:131-7.
9. Mullick FG, Moran CA, Ishak KG. Total parenteral nutrition: a histological analysis of the liver changes in 20 children. Mod Pathol 1994;7:190-4.
10. Meehan JJ, Georgeson KE. Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome. J Pediatr Surg 1997;32:473-5.
11. Kaufman SS. Prevention of parenteral nutrition-associated liver disease in children. Pediatr Transplant 2002;6:37-42.
12. Goulet O, Girot R, Maier-Redelsperger M, et al. Hematologic disorders following prolonged use of intravenous fat emulsions in children. JPEN J Parenter Enteral Nutr 1986;10:284-8.
13. Colomb V, Jobert-Giraud A, Lacaille F, et al. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr 2000;24:345-50.
14. Colomb V, Fabeiro M, Dabbas M, et al. Central venous catheter-related infections in children on long-term home parenteral nutrition: incidence and risk factors. Clin Nutr 2000;19:355-9.
15. Pierro A, van Saene H, Jones M, et al. Clinical impact of abnormal gut flora in infants receiving parenteral nutrition. Ann Surg 1998;227:547-52.
16. van Saene HKF, Taylor N, Donnell SC, et al. Gut overgrowth with abnormal flora: the missing link in parenteral nutrition-related sepsis in surgical neonates. Eur J Clin Nutr 2003;57:548-53.
17. Donnell SC, Taylor N, van Saene HKF, et al. Infection rates in surgical neonates and infants receiving parenteral nutrition: a five-year prospective study. J Hosp Infect 2002;52:273-80.
18. Okada Y, Klein N, van Saene H, et al. Small volumes of enteral feedings normalise immune function in infants receiving parenteral nutrition. J Pediatr Surg 1998;33:16-9.
19. McAndrew HF, Lloyd DA, Rintala R, et al. Intravenous glutamine or short-chain fatty acids reduce central venous catheter infection in a model of total parenteral nutrition. J Pediatr Surg 1999;34:281-5.
20. McAndrew HF, Lloyd DA, Rintala R, et al. The effects of intravenous epidermal growth factor on bacterial translocation and central venous catheter infection in the rat total parenteral nutrition model. Pediatr Surg Int 2000;16:169-73.
21. Oudemans-van Straeten HM, van Saene HKF, Zandstra DF. Selective decontamination of the digestive tract: use of the correct antibiotics is crucial. Crit Care Med 2002;30:38-43.
22. Donnell SC, Taylor N, van Saene HKF. Translocation cannot be ignored during parenteral nutrition. J Hosp Infect 2003;54:165-7.
23. Nataro JP, Corcoran L, Zirin S, et al. Prospective analysis of coagulase-negative staphylococcal infection in hospitalized infants. J Pediatr 1994;125:798-804.
24. Okada Y, Klein NJ, van Saene HKF, et al. Bactericidal activity against coagulase-negative staphylococci is impaired in infants receiving long-term parenteral nutrition. Ann Surg 2000;231: 276-81.
25. Romeo C, Eaton S, Quant PA, et al. Neonatal oxidative liver metabolism: effects of hydrogen peroxide, a putative mediator of septic damage. J Pediatr Surg 1999;34:1107-11.
26. Williams EJ, Gaca MDA, Brigstock DR, et al. Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. J Hepatol 2000;32:754-61.
27. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 2000;21:49-98.
28. Wu J, Zern MA. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 2000;35:665-72.